Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China
· Delayed Price · Currency is CNY 5.76
-0.06 (-1.03%)
Apr 30, 2026, 1:45 PM CST
SHE:300039 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 6,088 | 6,307 | 6,464 | 6,956 | 8,431 | 6,443 | Upgrade
|
| Market Cap Growth | -12.74% | -2.43% | -7.07% | -17.49% | 30.84% | 26.49% | Upgrade
|
| Enterprise Value | 5,001 | 4,673 | 5,145 | 6,224 | 6,828 | 5,042 | Upgrade
|
| Last Close Price | 5.82 | 6.03 | 6.05 | 6.40 | 7.69 | 5.83 | Upgrade
|
| PE Ratio | 23.50 | 22.64 | 17.21 | 21.22 | 44.19 | 45.99 | Upgrade
|
| Forward PE | - | 24.15 | 24.15 | 24.15 | 24.15 | 24.15 | Upgrade
|
| PS Ratio | 5.88 | 5.47 | 4.39 | 4.36 | 7.54 | 5.86 | Upgrade
|
| PB Ratio | 1.30 | 1.43 | 1.58 | 1.73 | 2.24 | 2.12 | Upgrade
|
| P/TBV Ratio | 1.35 | 1.48 | 1.64 | 1.75 | 2.27 | 2.16 | Upgrade
|
| P/FCF Ratio | 36.62 | 30.96 | 46.70 | 19.67 | 24.45 | 77.14 | Upgrade
|
| P/OCF Ratio | 32.09 | 27.34 | 23.17 | 18.18 | 22.40 | 51.11 | Upgrade
|
| PEG Ratio | - | 0.97 | 0.97 | 0.97 | 0.97 | 0.97 | Upgrade
|
| EV/Sales Ratio | 4.83 | 4.05 | 3.49 | 3.91 | 6.10 | 4.58 | Upgrade
|
| EV/EBITDA Ratio | 17.82 | 15.20 | 13.18 | 17.92 | 32.02 | 32.91 | Upgrade
|
| EV/EBIT Ratio | 20.35 | 17.15 | 14.50 | 20.09 | 37.62 | 42.25 | Upgrade
|
| EV/FCF Ratio | 30.08 | 22.94 | 37.17 | 17.60 | 19.80 | 60.36 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | - | - | - | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.01 | 0.01 | - | - | - | Upgrade
|
| Debt / FCF Ratio | 0.03 | 0.02 | 0.04 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.23 | -0.23 | -0.41 | -0.19 | -0.22 | -0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.87 | -3.37 | -4.34 | -2.16 | -3.90 | -9.49 | Upgrade
|
| Net Debt / FCF Ratio | -6.54 | -5.08 | -12.23 | -2.13 | -2.41 | -17.41 | Upgrade
|
| Asset Turnover | 0.21 | 0.25 | 0.32 | 0.36 | 0.29 | 0.35 | Upgrade
|
| Inventory Turnover | 1.09 | 1.14 | 1.52 | 1.88 | 1.52 | 1.31 | Upgrade
|
| Quick Ratio | 8.18 | 8.68 | 9.49 | 3.86 | 4.72 | 10.85 | Upgrade
|
| Current Ratio | 11.09 | 13.41 | 10.40 | 4.41 | 5.32 | 11.82 | Upgrade
|
| Return on Equity (ROE) | 5.82% | 6.53% | 9.22% | 8.39% | 5.59% | 4.98% | Upgrade
|
| Return on Assets (ROA) | 3.14% | 3.66% | 4.88% | 4.38% | 2.98% | 2.39% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.16% | 8.12% | 10.76% | 8.50% | 6.75% | 7.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.00% | 5.90% | 8.30% | 7.30% | 4.60% | 3.80% | Upgrade
|
| Earnings Yield | 4.26% | 4.42% | 5.81% | 4.71% | 2.26% | 2.17% | Upgrade
|
| FCF Yield | 2.73% | 3.23% | 2.14% | 5.08% | 4.09% | 1.30% | Upgrade
|
| Dividend Yield | 1.05% | - | 1.65% | 1.56% | 0.78% | 0.86% | Upgrade
|
| Payout Ratio | 52.48% | 48.83% | 27.85% | 19.14% | 27.41% | 22.59% | Upgrade
|
| Buyback Yield / Dilution | -0.03% | -0.02% | -0.00% | 0.02% | -0.01% | -0.04% | Upgrade
|
| Total Shareholder Return | 1.02% | -0.02% | 1.65% | 1.59% | 0.77% | 0.81% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.